2007
DOI: 10.1590/s0102-86502007000100008
|View full text |Cite
|
Sign up to set email alerts
|

Myocardial protection by continuous, blood, antegrade-retrograde cardioplegia in rabbits

Abstract: Purpose:To study the effectiveness of the continuous, blood, antegrade-retrograde cardioplegia in an experimental model of isolated heart, evaluating ventricular function. Methods: Rabbits were divided into four groups: Control-C(n=10); ischemic crystalloid cardioplegia-IC(n=10); ischemic blood cardioplegia-IB(n=10); ischemic non cardioplegia-INC(n=10). After the ischemic protocol period the ventricular function was analyzed by the intra-ventricular balloon technique.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0
1

Year Published

2008
2008
2012
2012

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 10 publications
0
2
0
1
Order By: Relevance
“…Several solutions have been described for organ transplants [17][18][19]. The solution used by us was described by Martins et al [20]. It is routinely used in our department as cardioplegic solution in conventional cardiac surgery, and we are not aware of its use as a solution for preserving organs for transplant.…”
Section: Discussionmentioning
confidence: 99%
“…Several solutions have been described for organ transplants [17][18][19]. The solution used by us was described by Martins et al [20]. It is routinely used in our department as cardioplegic solution in conventional cardiac surgery, and we are not aware of its use as a solution for preserving organs for transplant.…”
Section: Discussionmentioning
confidence: 99%
“…(11) yaptıkları deneysel çalışmada, kan kardiyoplejisinin ventriküler fonksiyonu daha iyi koruduğunu göstermişlerdir. Flack ve ark.…”
unclassified
“…A constant flow of tepid or warm oxygenated blood is infused through the aorta and/or coronary sinus while the cardioplegic components are added in-line just before reaching the patient. A miniplegic formulation is commercially available in Brazil, (Braile Biomédica, São José do Río Preto, Brazil) (1,2). This technique requires a formulation for cardioplegic induction and another for cardioplegic maintenance ( Table 1 ).…”
mentioning
confidence: 99%